Suraksha Diagnostic Ltd corrects Q2 FY27 results, reporting ₹1,005.75 million total income and 69% YoY PAT growth
- EBITDA rose 45% YoY to ₹363.17 million; margin expanded to 36.7% from 31.7%.
- PAT increased 69% YoY to ₹149.50 million.
- Total tests reached 2.40 million (+9%); tests per patient were 5.70 (-2%), while average revenue per test was ₹412 (+15%).
